IP Library Granted Patent US 10,166,334
Granted Patent B2
US 10,166,334 · App. 12/569,529 · Granted Jan 1, 2019

Medicine injection apparatuses

Inventor: Ronald E. Wyrick (Spokane, WA)
Assignee: Washington Biotech Corporation
A61M5/2033A61M5/2459A61M5/31511A61M5/3204A61M5/46A61M2005/206A61M2005/2013A61M2005/2073A61M2005/3267
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,166,334
App. No.
12/569,529
Granted
Jan 1, 2019
Kind
B2
Abstract

A medicine injector in which a barrel with a receiving cavity is adapted to slidably receive a syringe subassembly for axial movement therein. Upon removal of a safety and release of a syringe driver, the syringe driver moves forward and injects the syringe needle. Penetration controls are shown for controlling needle penetration depth. In one form the penetration control uses a sleeve and spring which are radially adjacent. A cushioning ring or other cushion may be used to reduce syringe breakage. A load distribution and guide ring may be used to distribute loading applied to the syringe and help guide the moving syringe.

Claims (38)

1. An apparatus forming a medicine injector, comprising:

a barrel;

a receiving cavity within the barrel, the receiving cavity configured to receive a medicine ampule and needle assembly with an injection needle capable of being projected from the barrel to perform an injection;

a driver configured to operate within the barrel, the driver configured to move the needle into an injection position and dispense a medicine from the medicine ampule; and

a penetration controller configured to achieve a desired needle penetration depth when engaging the medicine ampule and needle assembly, the penetration controller comprising:

a control sleeve having flange lobes;

a spring located radially adjacent the control sleeve, wherein the control sleeve resides between the barrel and the spring in one cross section, and the spring includes at least one winding engaging the flange lobes; and

a cushion ring between the driver and the control sleeve.

2. The apparatus as recited by claim 1 wherein the control sleeve is configured to engage the cushion ring when the injection needle is at the desired needle penetration depth.

3. The apparatus as recited by claim 1 wherein the needle assembly comprises a double needle assembly.

4. The apparatus as recited by claim 1 wherein the cushion ring is configured to expand radially when the driver moves the needle into the injection position.

5. The apparatus as recited by claim 1 further comprising a load distribution ring associated with the cushion ring.

6. An injection apparatus, comprising:

a barrel;

a receiving cavity within the barrel, the receiving cavity configured to receive a syringe subassembly, the syringe subassembly comprising an ampule for housing fluid medication and a needle capable of being projected from the barrel to perform an injection;

a driver configured to move the syringe subassembly into an injection position to dispense the fluid medication from the needle;

a penetration controller configured to stop movement of the needle at a needle penetration depth when engaging the syringe subassembly, the penetration controller comprising:

a control sleeve having flange lobes;

a spring located radially adjacent the control sleeve, wherein the control sleeve resides between the barrel and the spring in one cross section, and the spring includes at least one winding engaging the flange lobes; and

a cushioning ring between the driver and the control sleeve.

7. The apparatus as recited by claim 6 wherein the cushioning ring is configured to be compressed by the syringe subassembly when the needle is at the needle penetration depth.

8. The apparatus as recited by claim 6 wherein the cushioning ring is configured to expand radially when the driver moves the syringe subassembly to the injection position.

9. The apparatus as recited by claim 6 wherein the syringe subassembly comprises a double needle assembly.

10. The apparatus as recited by claim 6 further comprising a load distribution ring associated with the cushioning ring.

11. The apparatus as recited by claim 6 wherein the penetration controller further comprises a penetration control abutment surface.

12. An apparatus comprising:

a barrel;

a syringe subassembly located within the barrel, the syringe subassembly having an ampule for housing a fluid medication, a needle, and a plunger for forcing the fluid medication from the ampule through the needle;

a driver for driving the syringe subassembly to penetrate flesh and displace the fluid medication through the needle;

a penetration controller configured to stop movement of the syringe subassembly at a needle penetration depth when engaging the syringe subassembly, the penetration controller comprising:

a control sleeve having flange lobes; and

a spring located radially adjacent the control sleeve, wherein the control sleeve resides between the barrel and the spring in one cross section, and the spring includes at least one winding engaging the flange lobes; and

a cushion ring between the driver and the control sleeve.

13. The apparatus as recited by claim 12 wherein the cushion ring is configured to expand radially when the driver moves the syringe subassembly.

14. The apparatus as recited by claim 12 further comprising a load distribution ring associated with the cushion ring.

15. The apparatus as recited by claim 14 wherein the control sleeve is configured to contact the load distribution ring when the syringe subassembly is at the needle penetration depth.

16. The apparatus as recited by claim 12 wherein an end of the spring is adapted to receive the syringe subassembly.

17. The apparatus as recited by claim 12 wherein the syringe subassembly comprises a double needle assembly.

Assignments (1)
SECURITY AGREEMENT Recorded Apr 11, 2012
From: COREPHARMA, L.L.C.; COREPHARMA, INC.; COREPHARMA HOLDINGS, INC.; AMEDRA PHARMACEUTICALS LLC
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 028030/0820 →
Continuity (3)
Continuation 11982397 · Oct 31, 2007
Division 11006382 · Dec 6, 2004
Related Publication 20100100039A1 · Apr 22, 2010
Cited By (5)
US 12,343,515 US 12,434,010 US 12,521,495 US 12,527,919 US 12,527,920